Ipragliflozin, a sodium glucose co-transporter 2 inhibitor, reduces intrahepatic lipid content and abdominal visceral fat volume in patients with type 2 diabetes-Reference-Cited by-同舟云学术

Ipragliflozin, a sodium glucose co-transporter 2 inhibitor, reduces intrahepatic lipid content and abdominal visceral fat volume in patients with type 2 diabetes

Published:2017-08-11 Issue:14 Volume:18 Page:1433-1438
ISSN:1465-6566
Container-title:Expert Opinion on Pharmacotherapy
language:en
Short-container-title:Expert Opinion on Pharmacotherapy

Author:

Ohta Akio¹,Kato Hiroyuki¹,Ishii Satoshi¹,Sasaki Yosuke¹,Nakamura Yuta¹,Nakagawa Tomoko¹,Nagai Yoshio²^ORCID,Tanaka Yasushi¹

Affiliation:

1. Department of Internal Medicine, Division of Metabolism and Endocrinology, St. Marianna University School of Medicine, Kawasaki, Japan

2. Division of Metabolism and Endocrinology, Department of Internal Medicine, St. Marianna University School of Medicine, Kawasaki, Japan

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14656566.2017.1363888

Reference23 articles.

1. Abdominal obesity and metabolic syndrome

2. Non-alcoholic fatty liver disease as a cause and a consequence of metabolic syndrome

3. Bariatric Surgery for Weight Loss and Glycemic Control in Nonmorbidly Obese Adults With Diabetes

4. Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes

5. Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes

Cited by 53 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Diagnosis and Management of MASLD: An Metabolic Perspective of a Multisystem Disease;International Journal of Clinical Metabolism and Diabetes;2024-05-07

2. Metabolic effects of SGLT2i and metformin on 3-hydroxybutyric acid and lactate in db/db mice;International Journal of Biological Macromolecules;2024-04

3. Antihypertensive Effects of SGLT-2 Inhibitors and Progress in Research;Advances in Clinical Medicine;2024

4. Female-specific pancreatic cancer survival from CT imaging of visceral fat implicates glutathione metabolism in solid tumors;Academic Radiology;2023-12

5. Sodium-glucose co-transporter 2 inhibitors and Sarcopenia: A controversy that must be solved;Clinical Nutrition;2023-12